Literature DB >> 23948894

Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's disease.

Ron L H Handels1, Weili Xu, Debora Rizzuto, Barbara Caracciolo, Rui Wang, Bengt Winblad, Frans R J Verhey, Johan L Severens, Laura Fratiglioni, Manuela A Joore, Anders Wimo.   

Abstract

BACKGROUND: Empirical models of the natural history of Alzheimer's disease (AD) may help to evaluate new interventions for AD.
OBJECTIVE: We aimed to estimate AD-free survival time in people with mild cognitive impairment (MCI) and decline of cognitive and physical function in AD cases.
METHODS: Within the Kungsholmen project, 153 incident MCI and 323 incident AD cases (international criteria) were identified during 9 years of follow-up in a cognitively healthy cohort of elderly people aged ≥75 at baseline (n = 1,082). Global cognitive function was assessed with the Mini-Mental State Examination (MMSE), and daily life function was evaluated with the Katz index of activities of daily living (ADL) at each follow-up examination. Data were analyzed using parametric survival analysis and mixed effect models.
RESULTS: Median AD-free survival time of 153 participants with incident MCI was 3.5 years. Among 323 incident AD cases, the cognitive decline was 1.84 MMSE points per year, which was significantly associated with age. Physical functioning declined by 0.38 ADL points per year and was significantly associated with age, education, and MMSE, but not with gender.
CONCLUSION: Elderly people with MCI may develop AD in approximately 3.5 years. Both cognitive and physical function may decline gradually after AD onset. The empirical models can be used to evaluate long-term disease progression of new interventions for AD.

Entities:  

Mesh:

Year:  2013        PMID: 23948894     DOI: 10.3233/JAD-130296

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  7 in total

1.  Advance euthanasia directives: a controversial case and its ethical implications.

Authors:  David Gibbes Miller; Rebecca Dresser; Scott Y H Kim
Journal:  J Med Ethics       Date:  2018-03-03       Impact factor: 2.903

2.  A 36-month follow-up of decline in activities of daily living in individuals receiving domiciliary care.

Authors:  Anne-Sofie Helvik; Lisbeth D Høgseth; Sverre Bergh; Jūratė Šaltytė-Benth; Øyvind Kirkevold; Geir Selbæk
Journal:  BMC Geriatr       Date:  2015-04-14       Impact factor: 3.921

3.  The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study.

Authors:  Ilona Hallikainen; Janne Martikainen; Pei-Jung Lin; Joshua T Cohen; Raquel Lahoz; Tarja Välimäki; Kristiina Hongisto; Saku Väätäinen; Matti Vanhanen; Peter J Neumann; Tuomo Hänninen; Anne Maria Koivisto
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-12-11

4.  Burden of caregiving and its impact in the patients of acute lymphoblastic leukemia.

Authors:  Rina Kumari; Adarsh Kohli; Pankaj Malhotra; Sandeep Grover; Alka Khadwal
Journal:  Ind Psychiatry J       Date:  2018 Jul-Dec

5.  A 52 month follow-up of functional decline in nursing home residents - degree of dementia contributes.

Authors:  Anne-Sofie Helvik; Knut Engedal; Jūratė Saltytė Benth; Geir Selbæk
Journal:  BMC Geriatr       Date:  2014-04-10       Impact factor: 3.921

6.  Validation of the English Version of the Multimodal Assessment of Capacities in Severe Dementia (MAC-SD): A Cognitive and Functional Scale for Use in Severe Dementia.

Authors:  Sloane Heller; Alan Steinberg; Mark Sedler
Journal:  J Alzheimers Dis Rep       Date:  2017-12-16

7.  Distinguishing Frontotemporal Dementia From Alzheimer Disease Through Everyday Function Profiles: Trajectories of Change.

Authors:  Clarissa M Giebel; David Knopman; Eneida Mioshi; Mizanur Khondoker
Journal:  J Geriatr Psychiatry Neurol       Date:  2020-02-13       Impact factor: 2.680

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.